Grant: CIHR Fellowship
McGill University
$135,000.00
Investigating the role of APJ heterodimers in pain modulation
EF 2018-19
Résumé
A large number of currently prescribed drugs target G-protein coupled receptors (GPCRs). These transmembrane proteins form the most important protein family present at the cell surface. GPCRs are involved in transducing a signal from the surrounding cellular environment into intracellular activity. Drugs targeting the same binding pocket as the endogenous ligand may have an activity similar to that of the ligand (agonist), or may block its effect (antagonists). Prescribed drugs often have side effects that could be due to a lack of specificity of these molecules. Traditionally, GPCR signaling was conceptualized with monomeric receptors, however, it is now accepted that some GPCRs are able to associate with others to form heteromeric complexes. The close relationship maintained by two GPCRs in a dimeric complex could influence the intracellular signaling events triggered by each. In this study, we propose to evaluate the activity of dimers formed by the apelin receptor and the neurotensin NTS1 receptor, or the apelin receptor and the kappa-opioid receptor. These three GPCRs are known to have powerful analgesic properties, thus we would like to evaluate the role played by these heterodimeric complexes in pain modulation. A better understanding of the role of heterodimeric complexes involving the apelin receptor would allow the development of new molecules specifically targeting these GPCR dimers. Such drugs would be more efficient, more specific, and therefore, have fewer side effects.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
397425
Name
Besserer-Offroy Elie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating the role of APJ heterodimers in pain modulation
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Apelin; Biais Signaling; Cellular Signaling; G Protein-Coupled Receptor; Heterodimerization; Kappa-Opioid; Neurotensin; Pain; Signaling Complexes Formation
Abstract
A large number of currently prescribed drugs target G-protein coupled receptors (GPCRs). These transmembrane proteins form the most important protein family present at the cell surface. GPCRs are involved in transducing a signal from the surrounding cellular environment into intracellular activity. Drugs targeting the same binding pocket as the endogenous ligand may have an activity similar to that of the ligand (agonist), or may block its effect (antagonists). Prescribed drugs often have side effects that could be due to a lack of specificity of these molecules. Traditionally, GPCR signaling was conceptualized with monomeric receptors, however, it is now accepted that some GPCRs are able to associate with others to form heteromeric complexes. The close relationship maintained by two GPCRs in a dimeric complex could influence the intracellular signaling events triggered by each. In this study, we propose to evaluate the activity of dimers formed by the apelin receptor and the neurotensin NTS1 receptor, or the apelin receptor and the kappa-opioid receptor. These three GPCRs are known to have powerful analgesic properties, thus we would like to evaluate the role played by these heterodimeric complexes in pain modulation. A better understanding of the role of heterodimeric complexes involving the apelin receptor would allow the development of new molecules specifically targeting these GPCR dimers. Such drugs would be more efficient, more specific, and therefore, have fewer side effects.
Competitiondate
201811
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Besserer-Offroy, Elie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~